Start date: 01/07/2023
End date: 30/06/2027
Project Code: A4312_13207
Acronym: Vax2Muc - Fase 2
Vax2Muc will deliver (i) a prophylactic vaccine candidate against H. pylori as PoC, and (ii) a wealth of
knowledge and technologies that can be translated into the clinical development pipeline and are broadly applicable for various GI/AMR mucosal pathogens to significantly benefit the challenging field of mucosal vaccination and finally reduce disease burden from
AMR/GI diseases.
